3,581 Shares in Equifax, Inc. $EFX Bought by Callan Family Office LLC

Callan Family Office LLC purchased a new position in shares of Equifax, Inc. (NYSE:EFXFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,581 shares of the credit services provider’s stock, valued at approximately $568,000.

Several other large investors have also added to or reduced their stakes in the company. Allworth Financial LP purchased a new position in shares of Equifax in the second quarter worth about $604,000. B. Metzler seel. Sohn & Co. AG purchased a new stake in Equifax in the second quarter valued at approximately $463,000. Advisors Capital Management LLC acquired a new position in Equifax in the 2nd quarter worth approximately $359,000. Vise Technologies Inc. purchased a new position in Equifax during the 2nd quarter worth approximately $298,000. Finally, Knuff & Co LLC purchased a new position in Equifax during the 2nd quarter worth approximately $2,793,000. Hedge funds and other institutional investors own 96.20% of the company’s stock.

Equifax Trading Down 1.3%

Equifax stock opened at $192.16 on Wednesday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.92. Equifax, Inc. has a 12 month low of $150.74 and a 12 month high of $271.84. The stock’s 50 day simple moving average is $173.25 and its two-hundred day simple moving average is $178.19. The firm has a market cap of $22.58 billion, a PE ratio of 33.77, a P/E/G ratio of 1.56 and a beta of 1.30.

Equifax (NYSE:EFXGet Free Report) last issued its quarterly earnings data on Tuesday, July 21st. The credit services provider reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Equifax had a net margin of 10.73% and a return on equity of 21.61%. The business’s revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the company earned $2.00 EPS. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Analysts anticipate that Equifax, Inc. will post 8.58 earnings per share for the current year.

Equifax Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be given a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a yield of 1.2%. The ex-dividend date is Monday, August 31st. Equifax’s dividend payout ratio (DPR) is currently 39.37%.

Insiders Place Their Bets

In other Equifax news, CEO Mark W. Begor sold 37,791 shares of Equifax stock in a transaction on Friday, July 24th. The shares were sold at an average price of $172.16, for a total value of $6,506,098.56. Following the completion of the transaction, the chief executive officer owned 271,890 shares of the company’s stock, valued at approximately $46,808,582.40. The trade was a 12.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

EFX has been the topic of several recent research reports. Morgan Stanley dropped their price objective on shares of Equifax from $243.00 to $225.00 and set an “overweight” rating on the stock in a report on Wednesday, July 22nd. Needham & Company LLC reduced their target price on shares of Equifax from $265.00 to $245.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. BNP Paribas Exane decreased their target price on shares of Equifax from $195.00 to $185.00 and set a “neutral” rating for the company in a research report on Thursday, June 18th. Robert W. Baird lowered their price target on shares of Equifax from $245.00 to $232.00 and set an “outperform” rating on the stock in a report on Wednesday, July 22nd. Finally, UBS Group reaffirmed a “buy” rating and set a $220.00 price target on shares of Equifax in a research report on Wednesday, July 8th. Fourteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $216.89.

View Our Latest Stock Analysis on Equifax

Equifax Company Profile

(Free Report)

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.

Further Reading

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFXFree Report).

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.